Therapeutic Targets in Ischaemic Heart Disease S. H. Taylor OriginalPaper 18 October 2012 Pages: 1 - 8
Calcium Antagonists and Silent Myocardial Ischaemia G. Steinbeck OriginalPaper 18 October 2012 Pages: 15 - 20
The Molecular Basis for the Use of Calcium Antagonists in Ischaemic Heart Disease Winifred G. Nayler OriginalPaper 18 October 2012 Pages: 21 - 27
Primary Prevention Potential of the Calcium Antagonists Kjell Midtbø OriginalPaper 18 October 2012 Pages: 28 - 32
The Importance of Stress-Induced Cardiac Wall Motion Abnormalities in the Evaluation of Drug Intervention Sabino IlicetoCarlo CaiatiPaolo Rizzon OriginalPaper 18 October 2012 Pages: 33 - 36
Secondary and Tertiary Prevention with Calcium Antagonists in Coronary Artery Disease Felix Burkart OriginalPaper 18 October 2012 Pages: 37 - 42
